|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4184 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| C07D 403/04 | (2006.01) |
| (11) | Patento numeris | 2722046 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14151089.1 |
| Europos patento paraiškos padavimo data | 2008-10-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-04-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-12-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 979643 P | 2007-10-12 | US |
| (72) |
Kolaczkowski, Lawrence, US
|
| (73) |
AbbVie Ireland Unlimited Company,
70 Sir John Rogerson`s Quay, Dublin 2,
IE
|
| (54) | 2-((R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide crystalline form 1 |
| 2-((R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide crystalline form 1 |